1. European Commission. Regulation (EC) No. 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. Official Journal of the European Communities 2000;L18:1–5.
2. Regulatory framework for the treatment of orphan diseases;Shah,2006
3. Understanding orphan drug regulations: an EU and U.S. comparative analysis;Grienenberger;Journal of BioLaw and Business,2004
4. Assessing the performance of EMEA's centralized procedure: a comparative analysis with the US FDA;Faden;Drug Information Journal,2008
5. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy;Liu;Journal of Public Health Policy,2010